[F14.—(1) Subject to sub-paragraph (2), the applicant or holder to whom notice is given under paragraph 2 may, within the time allowed after the notification was given—U.K.
(a)notify the licensing authority that he wishes to appear before and be heard by a person appointed by the licensing authority with respect to the decision; or
(b)make representations in writing to the licensing authority with respect to the decision referred to in the notice.
(2) If the applicant or holder to whom notice is given under paragraph 2 makes written representations in accordance with sub-paragraph (1)(b), the licensing authority shall take those representations into account before deciding whether to—
(a)grant the authorisation,
(b)revoke, vary or suspend the authorisation, or
(c)confirm or alter their decision,
as the case may be.]
Textual Amendments
F1Sch. 8 paras. 4, 5 substituted (30.10.2005) by The Medicines (Advisory Bodies) (No. 2) Regulations 2005 (S.I. 2005/2754), reg. 1(2)(b), Sch. 3 para. 6